Gynecologic Extramammary Paget's Disease
Part of paid clinical trials in Rochester, Minnesota.
- Sponsor
- Mayo Clinic
- Study ID
- NCT03564483
- Status
- Recruiting
Conditions
- Extramammary Paget Disease
- Extramammary Paget's Disease
- Extramammary Paget's Disease Vulva Invasive
- Extramammary Paget's Disease of Anal Canal (Diagnosis)
- Extramammary Paget's Disease of Anus (Diagnosis)
- Extramammary Paget's Disease of Skin
- Extramammary Paget's Disease of Vagina (Diagnosis)
- Extramammary Paget's Disease of Vulva (Diagnosis)
- Paget Disease, Extramammary
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
In addition to evaluating treatment outcomes, tissue samples and swabs will be collected as part of this study to allow physicians to better understand Extramammary Paget's Disease (EMPD). The researchers also want to learn more about the microorganisms (microbiome) that live on or near the areas of skin affected by EMPD, in order to better understand this condition.
Key Dates
- Start date
- Feb 19, 2018
- Status verified
- Jan 2026
- Primary completion
- Dec 31, 2050
- Completion
- Dec 31, 2050
Study Design
- Enrollment
- 100 participants (estimated)
Arms
- Arm: Registry Observational StudyAll women presenting for evaluation of Extramammary Paget's Disease (EMPD) at Mayo Clinic in Rochester MN.
Primary Outcome Measure
Collect prospective data including outcomes and long-term survival in women with extramammary Paget's disease (EMPD). [ Time Frame: 25 years ]
Central Contacts
- Maureen A. Lemens, R.N.507-293-1487
- Karen P Ishitani, RN507-538-5355
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic | Rochester | Minnesota | 55905 | Jamie N. Bakkum-Gamez, M.D. (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Rochester, MN
By research site
Related Studies
- A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor CancerPHASE1 · Recruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey
- A Study of Fluorescein Sodium in People Undergoing Vulvectomy for Extramammary Paget's Disease (EMPD)PHASE2 · Recruiting · Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey